ENTRY       D11066            Mixture   Drug
NAME        Ertugliflozin and sitagliptin;
            Steglujan (TN)
PRODUCT     STEGLUJAN (Merck Sharp & Dohme LLC)
COMPONENT   (Ertugliflozin pidolate [DR:D11043] | Ertugliflozin [DR:D10313]), (Sitagliptin phosphate [DR:D06645] | Sitagliptin [DR:D08516] | Sitagliptin phosphate [DR:D12294])
CLASS       Antidiabetic agent
             DG02044  Hypoglycemic agent
              DG03035  Combination of DPP-4 inhibitor and SGLT2 inhibitor
            Metabolizing enzyme substrate
             DG02924  UGT substrate
              DG03188  UGT1A9 substrate
              DG03190  UGT2B7 substrate
REMARK      ATC code: A10BD24
            Product: D11066<US>
EFFICACY    Antidiabetic
  DISEASE   Type 2 diabetes mellitus [DS:H00409]
COMMENT     Ertugliflozin is primarily metabolized by UGT1A9 and UGT2B7.
METABOLISM  Enzyme: UGT1A9 [HSA:54600], UGT2B7 [HSA:7364]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
                A10BD Combinations of oral blood glucose lowering drugs
                 A10BD24 Sitagliptin and ertugliflozin
                  D11066  Ertugliflozin and sitagliptin &lt;US&gt;
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Antidiabetic Combinations
               Ertugliflozin/ Sitagliptin
                D11066  Ertugliflozin and sitagliptin
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               DG03035  Combination of DPP-4 inhibitor and SGLT2 inhibitor
                D11066  Ertugliflozin and sitagliptin
             Metabolizing enzyme substrate
              DG02924  UGT substrate
               DG03188  UGT1A9 substrate
                D11066  Ertugliflozin and sitagliptin
               DG03190  UGT2B7 substrate
                D11066  Ertugliflozin and sitagliptin
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               D11066  Ertugliflozin and sitagliptin
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11066
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D11066
DBLINKS     PubChem: 375581013
///
